Daicel

Minato, Japan Founded: 1919 • Age: 107 yrs Listed
Specialty chemicals are produced by Daicel in Japan since 1919.

About Daicel

Daicel is a publicly listed company based in Minato (Japan) founded in 1919. Specialty chemicals are produced by Daicel in Japan since 1919. Daicel has completed 3 acquisitions, including Arbor Biosciences, Lomapharm and Special Devices. Its chief executive, as recorded, is Misao Fudaba. Its website daicel.com draws about 63 thousand monthly visits. Its Indian entity Daicel Safety Systems India Private Limited reported revenue of β‚Ή166 Cr. Its focus areas include Chemicals and Materials, Diversified Chemicals and Diversified.

Company details

Daicel was established in 1919 in Minato City, Japan, as a key player in the chemical sector. Operations encompass the manufacture and distribution of various organic and cellulose-based chemicals for industrial applications. Products are supplied to sectors including pharmaceuticals, electronics, and automotive industries. Headquarters remain in Japan, with global reach through international partnerships and exports. Leadership is provided by CEO Misao Fudaba.

  • Headquarters Minato, Japan
  • Stage Public
  • Sectors
    Chemicals & Materials
  • Website category Heavy Industry and Engineering · Chemical Industry
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website daicel.com
  • Social YouTube
  • Legal Name Daicel Corporation
Key Metrics
  • Indian entity revenue
    ₹166 Cr

    FY 2025 · +987% YoY

  • Indian entity net loss
    -₹33.56 Cr

    FY 2025 · -20% margin

  • Indian entity EBITDA
    ₹2.53 Cr

    FY 2025 · 2% margin

  • Investments & Acquisitions

Apps and channels of Daicel

its YouTube channel Daicel Channel | 株式会社ダイセル公式チャンネル has 2.43K subscribers and 30 videos.

Daicel Channel | 株式会社ダイセル公式チャンネル
YouTube 2.43K subscribers 30 videos Science & Technology
Open channel

Videos from Daicel

The most watched videos on Daicel's YouTube channel, Daicel Channel | 株式会社ダイセル公式チャンネル (2.43K subscribers). Click a video to play it here.

2025_TV-CM_「砂浜」篇_15秒
1.6M views
2025_TV-CM_「砂浜」篇_30秒
756.4K views
2023_TV-CM_「100年かけて磨いた技術」篇
17.3K views
ダイセル播磨工場へようこそ
6.8K views

More on Daicel Channel | 株式会社ダイセル公式チャンネル.

Board of directors of Daicel Safety Systems India Private Limited (Daicel)

Daicel Safety Systems India Private Limited is the primary company behind Daicel. The board of Daicel Safety Systems India Private Limited currently have 5 directors; the longest-serving is Ken Bando, appointed in 2019. 8 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Ken Bando
DIN 08407902
Director01 Apr 20197 yrs 7 moDaicel Safety Systems India Private Limited
Lakshmi Narayana Chennuru
DIN 05314602
Director21 Sep 20224 yrs 1 moDaicel Safety Systems India Private Limited
Chihiro Aoki
DIN 10039616
Managing Director23 Jan 20233 yrs 9 moDaicel Safety Systems India Private Limited
Eiichi Ryobo
DIN 10172589
Director23 May 20233 yrs 5 moDaicel Safety Systems India Private Limited
Hiromasa Tsukuma
DIN 11078524
Director28 Apr 20251 yr 6 moDaicel Safety Systems India Private Limited

People of Daicel

6 people are tracked at Daicel (2 in leadership, 4 in team).

NameRoleGroup
Misao Fudaba
CEOLeadership
Yoshimi Ogawa
President and CEOLeadership
Mitsuteru Mutsuda
Executive OfficerTeam
Taku I.
Senior Manager - Business Strategy, Business PlanningTeam
Aulia Khilmi Rizgi
Technology DevelopmentTeam
Ippei Kinuta
HR ManagerTeam
Premium access

Complete people profiles for Daicel

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Daicel

Daicel is a publicly listed company on the TSE with ticker symbol 4202 in Japan, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date16 May 1949
  • Listed onTSE: 4202
  • Listed entityDaicel Corporation
  • Exchange sectorProcess industries
  • ISINJP3485800001
  • Share price1,476.00 JPY (+1.58% on the day) · 2026-10-14
  • Market capitalisation370,384,168,808.00 JPY
  • Price to earnings41.7
  • EPS (diluted, trailing year)35.42 JPY
  • Dividend yield4.47%
  • Volume (last session)1,417,300

Financials of Daicel

Figures of Daicel Safety Systems India Private Limited, the primary company behind Daicel, for FY 2025. Revenue was ₹166 Cr (+987% year on year). Net loss was -₹33.56 Cr (-20% margin). EBITDA was ₹2.53 Cr (2% margin). Revenue has grown at a compounded annual rate of +241% over three years and +125% over five years.

  • ₹166 CrRevenue · FY 2025 · +987% YoY
  • -₹33.56 CrNet loss · -20% margin
  • ₹2.53 CrEBITDA · 2% margin
  • ₹121 CrPaid-up capital
  • +241%Revenue CAGR, 3 years
  • +125%Revenue CAGR, 5 years
Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2025579.63B JPY10.18B JPY85.41B JPY
2024586.53B JPY49.48B JPY102.38B JPY
2023558.06B JPY55.84B JPY96.10B JPY
2022538.03B JPY40.68B JPY79.08B JPY
2021467.94B JPY31.25B JPY78.89B JPY

Balance sheet, profit and loss, cash flow and ratios of Daicel Safety Systems India Private Limited are on its company page.

Premium access

Detailed financial statements for Daicel

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Daicel

Daicel has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Arbor Biosciences, Lomapharm and Special Devices.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
DNA analysis microarrays are provided by Arbor Biosciences.
arborbiosci.comDetroit, United States2006Jan 2019β€’β€’β€’β€’
Pharmaceutical drugs are manufactured by Lomapharm in Germany since 1878.
lomapharm.deEmmerthal, Germany1878Jun 2018β€’β€’β€’β€’
Advanced sunglasses and eyeglasses are manufactured with proprietary lens technologies.
specialdevices.comSimi Valley, United States1976Mar 2012β€’β€’β€’β€’
Premium access

Complete acquisition details for Daicel

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Daicel

5 dated milestones of Daicel across 100 years, from founding to its latest funding, stage changes and deals.

  1. Founded Daicel is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Acquisition Acquires Special Devices.
  4. Acquisition Acquires Lomapharm.
  5. Acquisition Acquires Arbor Biosciences.

Web traffic of Daicel

The website of Daicel (daicel.com) receives about 62.9K visits a month and ranks #578,193 among all websites worldwide, #8,371 in Chemical Industry.

  • Monthly visits
    62.9K

    ▲ 29.8% vs previous month

  • Unique visitors
    24.4K

    per month

  • Global rank
    #578,193

    among all websites

  • Category rank
    #8,371

    Heavy Industry and Engineering · Chemical Industry

Similar websites

Websites whose visitors overlap most with Daicel. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
anp.co.jp
anp.co.jp
100%
#2,475,921–
gomutimes.co.jp
98%
#970,781View details
sankyo-chem.com
96%
#521,566View details
daishokasei.co.jp
daishokasei.co.jp
95%
#7,015,022–
sy-kogyo.co.jp
sy-kogyo.co.jp
94%
#1,337,242–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Daicel

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Daicel

Premium access

Complete news archive for Daicel

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Daicel

Daicel was founded in 1919.

Daicel is headquartered in Minato, Japan. It is registered at Minato, Tokyo, Japan.

Misao Fudaba is the CEO of Daicel, as recorded in our data.

The primary company behind Daicel, Daicel Safety Systems India Private Limited, reported revenue of β‚Ή166 Cr for FY 2025, up 987% year on year.

Daicel was established in 1919 in Minato City, Japan, as a key player in the chemical sector. Operations encompass the manufacture and distribution of various organic and cellulose-based chemicals for industrial applications. Products are supplied to sectors including pharmaceuticals, electronics, and automotive industries. Headquarters remain in Japan, with global reach through international partnerships and exports. Leadership is provided by CEO Misao Fudaba.

Yes, Daicel is publicly traded on TSE under the ticker symbol 4202.

Daicel has made 3 acquisitions, including Arbor Biosciences, Lomapharm, and Special Devices.

Daicel operates through Daicel Safety Systems India Private Limited.

The legal entities of Daicel currently have 6 directors, including Eiichi Ryobo, Chihiro Aoki, Shilpi Gupta and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available